ArticleAIDS (London, England)2020

Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection.

Nitya S Ramadoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.